ID   NPHP1_HUMAN             Reviewed;         732 AA.
AC   O15259; O14837;
DT   16-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   07-APR-2021, entry version 196.
DE   RecName: Full=Nephrocystin-1;
DE   AltName: Full=Juvenile nephronophthisis 1 protein;
GN   Name=NPHP1; Synonyms=NPH1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Fetal kidney;
RX   PubMed=9361039; DOI=10.1093/hmg/6.13.2317;
RA   Saunier S., Calado J., Heilig R., Silbermann F., Benessy F., Morin G.,
RA   Konrad M., Broyer M., Gubler M.-C., Weissenbach J., Antignac C.;
RT   "A novel gene that encodes a protein with a putative src homology 3 domain
RT   is a candidate gene for familial juvenile nephronophthisis.";
RL   Hum. Mol. Genet. 6:2317-2323(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 3-732 (ISOFORM 4), AND ALTERNATIVE SPLICING.
RX   PubMed=9326933; DOI=10.1038/ng1097-149;
RA   Hildebrandt F., Otto E., Rensing C., Nothwang H.G., Vollmer M., Adolphs J.,
RA   Hanusch H., Brandis M.;
RT   "A novel gene encoding an SH3 domain protein is mutated in nephronophthisis
RT   type 1.";
RL   Nat. Genet. 17:149-153(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INVOLVEMENT IN SLSN1.
RX   PubMed=9856524; DOI=10.1016/s0272-6386(98)70083-6;
RA   Caridi G., Murer L., Bellantuono R., Sorino P., Caringella D.A.,
RA   Gusmano R., Ghiggeri G.M.;
RT   "Renal-retinal syndromes: association of retinal anomalies and recessive
RT   nephronophthisis in patients with homozygous deletion of the NPH1 locus.";
RL   Am. J. Kidney Dis. 32:1059-1062(1998).
RN   [6]
RP   INTERACTION WITH NPHP4.
RX   PubMed=12244321; DOI=10.1038/ng996;
RA   Mollet G., Salomon R., Gribouval O., Silbermann F., Bacq D., Landthaler G.,
RA   Milford D., Nayir A., Rizzoni G., Antignac C., Saunier S.;
RT   "The gene mutated in juvenile nephronophthisis type 4 encodes a novel
RT   protein that interacts with nephrocystin.";
RL   Nat. Genet. 32:300-305(2002).
RN   [7]
RP   INTERACTION WITH INVS.
RX   PubMed=12872123; DOI=10.1038/ng1217;
RA   Otto E.A., Schermer B., Obara T., O'Toole J.F., Hiller K.S., Mueller A.M.,
RA   Ruf R.G., Hoefele J., Beekmann F., Landau D., Foreman J.W., Goodship J.A.,
RA   Strachan T., Kispert A., Wolf M.T., Gagnadoux M.F., Nivet H., Antignac C.,
RA   Walz G., Drummond I.A., Benzing T., Hildebrandt F.;
RT   "Mutations in INVS encoding inversin cause nephronophthisis type 2, linking
RT   renal cystic disease to the function of primary cilia and left-right axis
RT   determination.";
RL   Nat. Genet. 34:413-420(2003).
RN   [8]
RP   INTERACTION WITH NPHP3.
RX   PubMed=12872122; DOI=10.1038/ng1216;
RA   Olbrich H., Fliegauf M., Hoefele J., Kispert A., Otto E., Volz A.,
RA   Wolf M.T., Sasmaz G., Trauer U., Reinhardt R., Sudbrak R., Antignac C.,
RA   Gretz N., Walz G., Schermer B., Benzing T., Hildebrandt F., Omran H.;
RT   "Mutations in a novel gene, NPHP3, cause adolescent nephronophthisis,
RT   tapeto-retinal degeneration and hepatic fibrosis.";
RL   Nat. Genet. 34:455-459(2003).
RN   [9]
RP   PHOSPHORYLATION AT SER-121; SER-123 AND SER-126, INTERACTION WITH PACS1,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND MUTAGENESIS OF SER-121;
RP   SER-123 AND SER-126.
RX   PubMed=16308564; DOI=10.1038/sj.emboj.7600885;
RA   Schermer B., Hoepker K., Omran H., Ghenoiu C., Fliegauf M., Fekete A.,
RA   Horvath J., Koettgen M., Hackl M., Zschiedrich S., Huber T.B.,
RA   Kramer-Zucker A., Zentgraf H., Blaukat A., Walz G., Benzing T.;
RT   "Phosphorylation by casein kinase 2 induces PACS-1 binding of nephrocystin
RT   and targeting to cilia.";
RL   EMBO J. 24:4415-4424(2005).
RN   [10]
RP   INVOLVEMENT IN JBTS4.
RX   PubMed=15138899; DOI=10.1086/421846;
RA   Parisi M.A., Bennett C.L., Eckert M.L., Dobyns W.B., Gleeson J.G.,
RA   Shaw D.W.W., McDonald R., Eddy A., Chance P.F., Glass I.A.;
RT   "The NPHP1 gene deletion associated with juvenile nephronophthisis is
RT   present in a subset of individuals with Joubert syndrome.";
RL   Am. J. Hum. Genet. 75:82-91(2004).
RN   [11]
RP   SUBCELLULAR LOCATION, AND DEVELOPMENTAL STAGE.
RX   PubMed=16885411; DOI=10.1681/asn.2005121351;
RA   Fliegauf M., Horvath J., von Schnakenburg C., Olbrich H., Mueller D.,
RA   Thumfart J., Schermer B., Pazour G.J., Neumann H.P., Zentgraf H.,
RA   Benzing T., Omran H.;
RT   "Nephrocystin specifically localizes to the transition zone of renal and
RT   respiratory cilia and photoreceptor connecting cilia.";
RL   J. Am. Soc. Nephrol. 17:2424-2433(2006).
RN   [12]
RP   INTERACTION WITH TNK2, AND TISSUE SPECIFICITY.
RX   PubMed=18477472; DOI=10.1016/j.bbrc.2008.05.016;
RA   Eley L., Moochhala S.H., Simms R., Hildebrandt F., Sayer J.A.;
RT   "Nephrocystin-1 interacts directly with Ack1 and is expressed in human
RT   collecting duct.";
RL   Biochem. Biophys. Res. Commun. 371:877-882(2008).
RN   [13]
RP   INTERACTION WITH AHI1.
RX   PubMed=18633336; DOI=10.1038/ki.2008.377;
RA   Eley L., Gabrielides C., Adams M., Johnson C.A., Hildebrandt F.,
RA   Sayer J.A.;
RT   "Jouberin localizes to collecting ducts and interacts with nephrocystin-
RT   1.";
RL   Kidney Int. 74:1139-1149(2008).
RN   [14]
RP   INTERACTION WITH PKD1, AND MUTAGENESIS OF PRO-203.
RX   PubMed=20856870; DOI=10.1371/journal.pone.0012719;
RA   Wodarczyk C., Distefano G., Rowe I., Gaetani M., Bricoli B., Muorah M.,
RA   Spitaleri A., Mannella V., Ricchiuto P., Pema M., Castelli M.,
RA   Casanova A.E., Mollica L., Banzi M., Boca M., Antignac C., Saunier S.,
RA   Musco G., Boletta A.;
RT   "Nephrocystin-1 forms a complex with polycystin-1 via a polyproline
RT   motif/SH3 domain interaction and regulates the apoptotic response in
RT   mammals.";
RL   PLoS ONE 5:E12719-E12719(2010).
RN   [15]
RP   INTERACTION WITH IQCB1; INVS AND NPHP4, AND SUBCELLULAR LOCATION.
RX   PubMed=21565611; DOI=10.1016/j.cell.2011.04.019;
RA   Sang L., Miller J.J., Corbit K.C., Giles R.H., Brauer M.J., Otto E.A.,
RA   Baye L.M., Wen X., Scales S.J., Kwong M., Huntzicker E.G., Sfakianos M.K.,
RA   Sandoval W., Bazan J.F., Kulkarni P., Garcia-Gonzalo F.R., Seol A.D.,
RA   O'Toole J.F., Held S., Reutter H.M., Lane W.S., Rafiq M.A., Noor A.,
RA   Ansar M., Devi A.R., Sheffield V.C., Slusarski D.C., Vincent J.B.,
RA   Doherty D.A., Hildebrandt F., Reiter J.F., Jackson P.K.;
RT   "Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes
RT   and pathways.";
RL   Cell 145:513-528(2011).
RN   [16]
RP   INTERACTION WITH PTK2B/PYK2, AND PHOSPHORYLATION AT TYR-46; TYR-349 AND
RP   TYR-721.
RX   PubMed=21357692; DOI=10.1074/jbc.m110.165464;
RA   Liebau M.C., Hopker K., Muller R.U., Schmedding I., Zank S., Schairer B.,
RA   Fabretti F., Hohne M., Bartram M.P., Dafinger C., Hackl M., Burst V.,
RA   Habbig S., Zentgraf H., Blaukat A., Walz G., Benzing T., Schermer B.;
RT   "Nephrocystin-4 regulates Pyk2-induced tyrosine phosphorylation of
RT   nephrocystin-1 to control targeting to monocilia.";
RL   J. Biol. Chem. 286:14237-14245(2011).
RN   [17]
RP   INTERACTION WITH KIF7.
RX   PubMed=21633164; DOI=10.1172/jci43639;
RA   Dafinger C., Liebau M.C., Elsayed S.M., Hellenbroich Y., Boltshauser E.,
RA   Korenke G.C., Fabretti F., Janecke A.R., Ebermann I., Nurnberg G.,
RA   Nurnberg P., Zentgraf H., Koerber F., Addicks K., Elsobky E., Benzing T.,
RA   Schermer B., Bolz H.J.;
RT   "Mutations in KIF7 link Joubert syndrome with Sonic Hedgehog signaling and
RT   microtubule dynamics.";
RL   J. Clin. Invest. 121:2662-2667(2011).
RN   [18]
RP   INVOLVEMENT IN JBTS4.
RX   PubMed=26477546; DOI=10.1016/j.ajhg.2015.09.009;
RG   Care4Rare Canada Consortium;
RA   Srour M., Hamdan F.F., McKnight D., Davis E., Mandel H.,
RA   Schwartzentruber J., Martin B., Patry L., Nassif C., Dionne-Laporte A.,
RA   Ospina L.H., Lemyre E., Massicotte C., Laframboise R., Maranda B.,
RA   Labuda D., Decarie J.C., Rypens F., Goldsher D., Fallet-Bianco C.,
RA   Soucy J.F., Laberge A.M., Maftei C., Boycott K., Brais B., Boucher R.M.,
RA   Rouleau G.A., Katsanis N., Majewski J., Elpeleg O., Kukolich M.K.,
RA   Shalev S., Michaud J.L.;
RT   "Joubert Syndrome in French Canadians and Identification of Mutations in
RT   CEP104.";
RL   Am. J. Hum. Genet. 97:744-753(2015).
RN   [19]
RP   STRUCTURE BY NMR OF 147-212, AND MUTAGENESIS OF LEU-180.
RX   PubMed=15723349; DOI=10.1002/prot.20344;
RA   le Maire A., Weber T., Saunier S., Broutin I., Antignac C., Ducruix A.,
RA   Dardel F.;
RT   "Solution NMR structure of the SH3 domain of human nephrocystin and
RT   analysis of a mutation-causing juvenile nephronophthisis.";
RL   Proteins 59:347-355(2005).
RN   [20]
RP   VARIANT NPHP1 ARG-342.
RX   PubMed=10839884; DOI=10.1016/s0022-3476(00)01001-5;
RA   Betz R., Rensing C., Otto E., Mincheva A., Zehnder D., Lichter P.,
RA   Hildebrandt F.;
RT   "Children with ocular motor apraxia type Cogan carry deletions in the gene
RT   (NPHP1) for juvenile nephronophthisis.";
RL   J. Pediatr. 136:828-831(2000).
RN   [21]
RP   VARIANT LEU-5, AND CHARACTERIZATION OF VARIANT LEU-5.
RX   PubMed=24746959; DOI=10.1016/j.ajhg.2014.03.017;
RA   Lindstrand A., Davis E.E., Carvalho C.M., Pehlivan D., Willer J.R.,
RA   Tsai I.C., Ramanathan S., Zuppan C., Sabo A., Muzny D., Gibbs R., Liu P.,
RA   Lewis R.A., Banin E., Lupski J.R., Clark R., Katsanis N.;
RT   "Recurrent CNVs and SNVs at the NPHP1 locus contribute pathogenic alleles
RT   to Bardet-Biedl syndrome.";
RL   Am. J. Hum. Genet. 94:745-754(2014).
CC   -!- FUNCTION: Together with BCAR1 it may play a role in the control of
CC       epithelial cell polarity (By similarity). Involved in the organization
CC       of apical junctions in kidney cells together with NPHP4 and
CC       RPGRIP1L/NPHP8 (By similarity). Does not seem to be strictly required
CC       for ciliogenesis (By similarity). Seems to help to recruit PTK2B/PYK2
CC       to cell matrix adhesions, thereby initiating phosphorylation of
CC       PTK2B/PYK2 and PTK2B/PYK2-dependent signaling (By similarity). May play
CC       a role in the regulation of intraflagellar transport (IFT) during cilia
CC       assembly. Required for normal retina development (By similarity). In
CC       connecting photoreceptor cilia influences the movement of some IFT
CC       proteins such as IFT88 and WDR19. Involved in spermatogenesis (By
CC       similarity). {ECO:0000250|UniProtKB:Q9QY53}.
CC   -!- SUBUNIT: Interacts with BCAR1, PTK2B/PYK2 and tensin. Interacts with
CC       INVS and NPHP3. Interacts with PACS1; the interaction is dependent on
CC       NPHP1 phosphorylation by CK2. Interacts with KIF7. Interacts with AHI1
CC       and TNK2. Interacts with NPHP4 in a complex containing NPHP1, NPHP4 and
CC       RPGRIP1L. Interacts with IQCB1; the interaction likely requires
CC       additional interactors. Interacts with ANKS3 (By similarity).Interacts
CC       with SPATA7 (By similarity). Interacts with FLNA (By similarity).
CC       {ECO:0000250|UniProtKB:Q9QY53, ECO:0000269|PubMed:12244321,
CC       ECO:0000269|PubMed:12872122, ECO:0000269|PubMed:12872123,
CC       ECO:0000269|PubMed:16308564, ECO:0000269|PubMed:18477472,
CC       ECO:0000269|PubMed:18633336, ECO:0000269|PubMed:20856870,
CC       ECO:0000269|PubMed:21357692, ECO:0000269|PubMed:21565611,
CC       ECO:0000269|PubMed:21633164}.
CC   -!- INTERACTION:
CC       O15259; Q13444: ADAM15; NbExp=4; IntAct=EBI-953828, EBI-77818;
CC       O15259; Q8N157: AHI1; NbExp=4; IntAct=EBI-953828, EBI-1049056;
CC       O15259; O75161: NPHP4; NbExp=18; IntAct=EBI-953828, EBI-4281852;
CC       O15259; P98161: PKD1; NbExp=2; IntAct=EBI-953828, EBI-1752013;
CC       O15259; Q14289: PTK2B; NbExp=2; IntAct=EBI-953828, EBI-298640;
CC   -!- SUBCELLULAR LOCATION: Cell junction {ECO:0000250|UniProtKB:Q9QY53}.
CC       Cell junction, adherens junction {ECO:0000250|UniProtKB:Q9QY53}. Cell
CC       projection, cilium {ECO:0000269|PubMed:16885411}. Cytoplasm,
CC       cytoskeleton, cilium axoneme {ECO:0000269|PubMed:16308564,
CC       ECO:0000269|PubMed:16885411}. Cell junction, tight junction. Note=In
CC       the retinal photoreceptor cell layer, localizes at the connecting
CC       cilium (By similarity). Colocalizes with E-cadherin and BCAR1 at or
CC       near the cell-cell adherens junctions (By similarity). Localized to
CC       respiratory cilia axoneme (PubMed:16308564, PubMed:16885411). Localized
CC       to the transition zone of respiratory cilia (PubMed:16885411).
CC       Localized to the transition zone of photoreceptor-connecting cilia and
CC       renal monocilia (By similarity). In cultured renal cells, it localizes
CC       diffusely in the cytoplasm but, as cells approach confluence, it
CC       accumulates at basolateral tight junctions (By similarity).
CC       {ECO:0000250|UniProtKB:Q9QY53, ECO:0000269|PubMed:16308564,
CC       ECO:0000269|PubMed:16885411}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=NPHP1;
CC         IsoId=O15259-1; Sequence=Displayed;
CC       Name=2; Synonyms=NPHP1-8A;
CC         IsoId=O15259-2; Sequence=VSP_003424;
CC       Name=3;
CC         IsoId=O15259-3; Sequence=VSP_010073, VSP_010074;
CC       Name=4;
CC         IsoId=O15259-4; Sequence=VSP_024381;
CC   -!- TISSUE SPECIFICITY: Widespread expression, with highest levels in
CC       pituitary gland, spinal cord, thyroid gland, testis, skeletal muscle,
CC       lymph node and trachea. Weakly expressed in heart, kidney and pancreas.
CC       Expressed in nasal epithelial cells (at protein level)
CC       (PubMed:16308564). Expressed in the renal collecting duct (at protein
CC       level) (PubMed:18477472). {ECO:0000269|PubMed:16308564,
CC       ECO:0000269|PubMed:18477472}.
CC   -!- DEVELOPMENTAL STAGE: During in vitro ciliogenesis translocalizes from
CC       the cytoplasm to the ciliary transition zone during epithelial cell
CC       polarization. {ECO:0000269|PubMed:16885411}.
CC   -!- DOMAIN: The SH3 domain mediates the stable interaction with Cas.
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylation by CK2 is required for the interaction with PACS1
CC       and the targeting to the base region of cilia.
CC       {ECO:0000269|PubMed:16308564, ECO:0000269|PubMed:21357692}.
CC   -!- DISEASE: Nephronophthisis 1 (NPHP1) [MIM:256100]: An autosomal
CC       recessive inherited disease characterized by anemia, polyuria,
CC       polydipsia, isosthenuria and death in uremia. Symmetrical destruction
CC       of the kidneys involving both tubules and glomeruli occurs. The
CC       underlying pathology is a chronic tubulo-interstitial nephropathy with
CC       characteristic tubular basement membrane thickening and medullary cyst
CC       formation. Associations with extrarenal symptoms, especially ocular
CC       lesions, are frequent. The age at death ranges from about 4 to 15
CC       years. {ECO:0000269|PubMed:10839884}. Note=The disease is caused by
CC       variants affecting the gene represented in this entry.
CC   -!- DISEASE: Senior-Loken syndrome 1 (SLSN1) [MIM:266900]: A renal-retinal
CC       disorder characterized by progressive wasting of the filtering unit of
CC       the kidney (nephronophthisis), with or without medullary cystic renal
CC       disease, and progressive eye disease. Typically this disorder becomes
CC       apparent during the first year of life. {ECO:0000269|PubMed:9856524}.
CC       Note=The disease is caused by variants affecting the gene represented
CC       in this entry.
CC   -!- DISEASE: Joubert syndrome 4 (JBTS4) [MIM:609583]: A disorder presenting
CC       with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal
CC       breathing abnormalities and psychomotor delay. Neuroradiologically, it
CC       is characterized by cerebellar vermian hypoplasia/aplasia, thickened
CC       and reoriented superior cerebellar peduncles, and an abnormally large
CC       interpeduncular fossa, giving the appearance of a molar tooth on
CC       transaxial slices (molar tooth sign). Additional variable features
CC       include retinal dystrophy and renal disease. Joubert syndrome type 4 is
CC       a phenotypically mild form. {ECO:0000269|PubMed:15138899,
CC       ECO:0000269|PubMed:26477546}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Nephronophthisis type 1 patients deficient for NPHP1
CC       show normal overall integrity of respiratory cilia.
CC   -!- SIMILARITY: Belongs to the nephrocystin-1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ001815; CAA05030.1; -; mRNA.
DR   EMBL; AF023674; AAC51771.1; -; mRNA.
DR   EMBL; AC013268; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC140479; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC009789; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC062574; AAH62574.1; -; mRNA.
DR   CCDS; CCDS2086.1; -. [O15259-4]
DR   CCDS; CCDS46384.1; -. [O15259-3]
DR   CCDS; CCDS46385.1; -. [O15259-1]
DR   CCDS; CCDS46386.1; -. [O15259-2]
DR   RefSeq; NP_000263.2; NM_000272.3. [O15259-4]
DR   RefSeq; NP_001121650.1; NM_001128178.1. [O15259-2]
DR   RefSeq; NP_001121651.1; NM_001128179.1. [O15259-3]
DR   RefSeq; NP_997064.2; NM_207181.2. [O15259-1]
DR   PDB; 1S1N; NMR; -; A=147-212.
DR   PDB; 6O1Q; NMR; -; A=1-115.
DR   PDBsum; 1S1N; -.
DR   PDBsum; 6O1Q; -.
DR   SMR; O15259; -.
DR   BioGRID; 110927; 91.
DR   CORUM; O15259; -.
DR   IntAct; O15259; 81.
DR   MINT; O15259; -.
DR   STRING; 9606.ENSP00000313169; -.
DR   iPTMnet; O15259; -.
DR   PhosphoSitePlus; O15259; -.
DR   BioMuta; NPHP1; -.
DR   MassIVE; O15259; -.
DR   PaxDb; O15259; -.
DR   PeptideAtlas; O15259; -.
DR   PRIDE; O15259; -.
DR   ProteomicsDB; 48545; -. [O15259-1]
DR   ProteomicsDB; 48546; -. [O15259-2]
DR   ProteomicsDB; 48547; -. [O15259-3]
DR   ProteomicsDB; 48548; -. [O15259-4]
DR   ABCD; O15259; 1 sequenced antibody.
DR   Antibodypedia; 18009; 146 antibodies.
DR   DNASU; 4867; -.
DR   Ensembl; ENST00000316534; ENSP00000313169; ENSG00000144061. [O15259-4]
DR   Ensembl; ENST00000355301; ENSP00000347452; ENSG00000144061. [O15259-3]
DR   Ensembl; ENST00000393272; ENSP00000376953; ENSG00000144061. [O15259-1]
DR   Ensembl; ENST00000445609; ENSP00000389879; ENSG00000144061. [O15259-2]
DR   Ensembl; ENST00000676053; ENSP00000502475; ENSG00000144061. [O15259-3]
DR   GeneID; 4867; -.
DR   KEGG; hsa:4867; -.
DR   UCSC; uc002tfl.6; human. [O15259-1]
DR   CTD; 4867; -.
DR   DisGeNET; 4867; -.
DR   GeneCards; NPHP1; -.
DR   GeneReviews; NPHP1; -.
DR   HGNC; HGNC:7905; NPHP1.
DR   HPA; ENSG00000144061; Tissue enhanced (skeletal).
DR   MalaCards; NPHP1; -.
DR   MIM; 256100; phenotype.
DR   MIM; 266900; phenotype.
DR   MIM; 607100; gene.
DR   MIM; 609583; phenotype.
DR   neXtProt; NX_O15259; -.
DR   OpenTargets; ENSG00000144061; -.
DR   Orphanet; 110; Bardet-Biedl syndrome.
DR   Orphanet; 220497; Joubert syndrome with renal defect.
DR   Orphanet; 93592; Juvenile nephronophthisis.
DR   Orphanet; 3156; Senior-Loken syndrome.
DR   PharmGKB; PA31706; -.
DR   VEuPathDB; HostDB:ENSG00000144061.12; -.
DR   eggNOG; ENOG502QU7K; Eukaryota.
DR   GeneTree; ENSGT00390000007701; -.
DR   HOGENOM; CLU_024987_1_0_1; -.
DR   InParanoid; O15259; -.
DR   OMA; SHYIQPE; -.
DR   OrthoDB; 676699at2759; -.
DR   PhylomeDB; O15259; -.
DR   TreeFam; TF320679; -.
DR   PathwayCommons; O15259; -.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   SignaLink; O15259; -.
DR   SIGNOR; O15259; -.
DR   BioGRID-ORCS; 4867; 11 hits in 988 CRISPR screens.
DR   ChiTaRS; NPHP1; human.
DR   EvolutionaryTrace; O15259; -.
DR   GeneWiki; NPHP1; -.
DR   GenomeRNAi; 4867; -.
DR   Pharos; O15259; Tbio.
DR   PRO; PR:O15259; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; O15259; protein.
DR   Bgee; ENSG00000144061; Expressed in skeletal muscle tissue and 160 other tissues.
DR   ExpressionAtlas; O15259; baseline and differential.
DR   Genevisible; O15259; HS.
DR   GO; GO:0005912; C:adherens junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0005923; C:bicellular tight junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0005911; C:cell-cell junction; IDA:UniProtKB.
DR   GO; GO:0005929; C:cilium; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-KW.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; NAS:UniProtKB.
DR   GO; GO:0031514; C:motile cilium; IDA:UniProtKB.
DR   GO; GO:0032391; C:photoreceptor connecting cilium; ISS:UniProtKB.
DR   GO; GO:0005198; F:structural molecule activity; NAS:UniProtKB.
DR   GO; GO:0030036; P:actin cytoskeleton organization; NAS:UniProtKB.
DR   GO; GO:0030030; P:cell projection organization; ISS:UniProtKB.
DR   GO; GO:0098609; P:cell-cell adhesion; NAS:UniProtKB.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0007588; P:excretion; TAS:ProtInc.
DR   GO; GO:1903348; P:positive regulation of bicellular tight junction assembly; IMP:UniProtKB.
DR   GO; GO:0090251; P:protein localization involved in establishment of planar polarity; IBA:GO_Central.
DR   GO; GO:0060041; P:retina development in camera-type eye; ISS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; NAS:UniProtKB.
DR   GO; GO:0048515; P:spermatid differentiation; ISS:UniProtKB.
DR   GO; GO:0007632; P:visual behavior; NAS:UniProtKB.
DR   CDD; cd11770; SH3_Nephrocystin; 1.
DR   InterPro; IPR039687; NPHP1.
DR   InterPro; IPR030642; NPHP1_SH3.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR15176:SF1; PTHR15176:SF1; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell projection;
KW   Ciliopathy; Cilium; Cilium biogenesis/degradation; Coiled coil; Cytoplasm;
KW   Cytoskeleton; Differentiation; Disease variant; Joubert syndrome;
KW   Leber congenital amaurosis; Nephronophthisis; Phosphoprotein;
KW   Reference proteome; Senior-Loken syndrome; SH3 domain; Spermatogenesis;
KW   Tight junction.
FT   CHAIN           1..732
FT                   /note="Nephrocystin-1"
FT                   /id="PRO_0000159585"
FT   DOMAIN          152..212
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   COILED          3..105
FT                   /evidence="ECO:0000255"
FT   COILED          127..150
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        116..147
FT                   /note="Glu-rich"
FT   COMPBIAS        212..227
FT                   /note="Glu-rich"
FT   MOD_RES         46
FT                   /note="Phosphotyrosine; by FAK2"
FT                   /evidence="ECO:0000269|PubMed:21357692"
FT   MOD_RES         121
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000305|PubMed:16308564"
FT   MOD_RES         123
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000305|PubMed:16308564"
FT   MOD_RES         126
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000305|PubMed:16308564"
FT   MOD_RES         349
FT                   /note="Phosphotyrosine; by FAK2"
FT                   /evidence="ECO:0000269|PubMed:21357692"
FT   MOD_RES         721
FT                   /note="Phosphotyrosine; by SRC"
FT                   /evidence="ECO:0000269|PubMed:21357692"
FT   VAR_SEQ         49..110
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_010073"
FT   VAR_SEQ         258..313
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_010074"
FT   VAR_SEQ         258..312
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9361039"
FT                   /id="VSP_003424"
FT   VAR_SEQ         313
FT                   /note="Q -> QQ (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:9326933"
FT                   /id="VSP_024381"
FT   VARIANT         5
FT                   /note="R -> L (changed function; unable to rescue the
FT                   corresponding loss of function zebrafish mutant which
FT                   displays a cilium function alteration phenotype;
FT                   dbSNP:rs190983114)"
FT                   /evidence="ECO:0000269|PubMed:24746959"
FT                   /id="VAR_077633"
FT   VARIANT         342
FT                   /note="G -> R (in NPHP1; associated with Cogan-type
FT                   congenital ocular motor apraxia; dbSNP:rs121907899)"
FT                   /evidence="ECO:0000269|PubMed:10839884"
FT                   /id="VAR_012160"
FT   MUTAGEN         121
FT                   /note="S->A: Impairs interaction with PACS1; when
FT                   associated with A-123 and A-126."
FT                   /evidence="ECO:0000269|PubMed:16308564"
FT   MUTAGEN         123
FT                   /note="S->A: Impairs interaction with PACS1; when
FT                   associated with A-121 and A-126."
FT                   /evidence="ECO:0000269|PubMed:16308564"
FT   MUTAGEN         126
FT                   /note="S->A: Impairs interaction with PACS1; when
FT                   associated with A-121 and A-123."
FT                   /evidence="ECO:0000269|PubMed:16308564"
FT   MUTAGEN         180
FT                   /note="L->P: Loss of SH3 domain fold."
FT                   /evidence="ECO:0000269|PubMed:15723349"
FT   MUTAGEN         203
FT                   /note="P->L: Does not affect fold stability, as assessed by
FT                   circular dichroism thermal denaturation melting curves and
FT                   by NMR spectroscopy. Affects interaction with PKD1."
FT                   /evidence="ECO:0000269|PubMed:20856870"
FT   HELIX           9..31
FT                   /evidence="ECO:0007744|PDB:6O1Q"
FT   HELIX           35..37
FT                   /evidence="ECO:0007744|PDB:6O1Q"
FT   HELIX           39..65
FT                   /evidence="ECO:0007744|PDB:6O1Q"
FT   TURN            69..72
FT                   /evidence="ECO:0007744|PDB:6O1Q"
FT   HELIX           77..104
FT                   /evidence="ECO:0007744|PDB:6O1Q"
FT   STRAND          155..159
FT                   /evidence="ECO:0007744|PDB:1S1N"
FT   STRAND          166..169
FT                   /evidence="ECO:0007744|PDB:1S1N"
FT   STRAND          175..181
FT                   /evidence="ECO:0007744|PDB:1S1N"
FT   STRAND          186..193
FT                   /evidence="ECO:0007744|PDB:1S1N"
FT   STRAND          195..197
FT                   /evidence="ECO:0007744|PDB:1S1N"
FT   STRAND          199..204
FT                   /evidence="ECO:0007744|PDB:1S1N"
FT   STRAND          207..209
FT                   /evidence="ECO:0007744|PDB:1S1N"
SQ   SEQUENCE   732 AA;  83299 MW;  270125F56F2C50F7 CRC64;
     MLARRQRDPL QALRRRNQEL KQQVDSLLSE SQLKEALEPN KRQHIYQRCI QLKQAIDENK
     NALQKLSKAD ESAPVANYNQ RKEEEHTLLD KLTQQLQGLA VTISRENITE VGAPTEEEEE
     SESEDSEDSG GEEEDAEEEE EEKEENESHK WSTGEEYIAV GDFTAQQVGD LTFKKGEILL
     VIEKKPDGWW IAKDAKGNEG LVPRTYLEPY SEEEEGQESS EEGSEEDVEA VDETADGAEV
     KQRTDPHWSA VQKAISEAGI FCLVNHVSFC YLIVLMRNRM ETVEDTNGSE TGFRAWNVQS
     RGRIFLVSKP VLQINTVDVL TTMGAIPAGF RPSTLSQLLE EGNQFRANYF LQPELMPSQL
     AFRDLMWDAT EGTIRSRPSR ISLILTLWSC KMIPLPGMSI QVLSRHVRLC LFDGNKVLSN
     IHTVRATWQP KKPKTWTFSP QVTRILPCLL DGDCFIRSNS ASPDLGILFE LGISYIRNST
     GERGELSCGW VFLKLFDASG VPIPAKTYEL FLNGGTPYEK GIEVDPSISR RAHGSVFYQI
     MTMRRQPQLL VKLRSLNRRS RNVLSLLPET LIGNMCSIHL LIFYRQILGD VLLKDRMSLQ
     STDLISHPML ATFPMLLEQP DVMDALRSSW AGKESTLKRS EKRDKEFLKS TFLLVYHDCV
     LPLLHSTRLP PFRWAEEETE TARWKVITDF LKQNQENQGA LQALLSPDGV HEPFDLSEQT
     YDFLGEMRKN AV
//
